Events
Biotrial Oncology: advancing cancer research at key conferences in 2025!
With nearly 35 years of experience in oncology research, Biotrial has launched Biotrial Oncology, a dedicated entity committed to advancing cancer treatment. Our mission is to accelerate the delivery of innovative therapies by closely collaborating with sponsors and key opinion leaders.
This year, we are excited to announce our participation in several major oncology conferences, including ASCO, ESMO, ASCPT, Phases Précoces, and AACR annual meeting. These events serve as key platforms for sharing our latest research and engaging with industry experts to push the boundaries of oncology drug development.
Meet us at AACR 2025
One of the major highlights of our conference schedule is AACR 2025, where Biotrial Oncology will showcase its expertise in both preclinical and clinical oncology research. Join us at Booth 4439 in Chicago from April 25th to 30th and explore our latest advancements.
We are proud to present three scientific posters at AACR:
- Preclinical Poster: Genetically characterized canine tumoral cell lines are relevant models to test the efficacy of new targeted therapies: Example of anti-MDM2 targeted therapy
- Date: April 30th
- Time: 9 AM – 12 PM
- Clinical Poster: History and summary of current practices for assessment of drug-induced QT-prolongation in oncology drug development
- Date: April 28th
- Time: 9 AM – 12 PM
- Biometrics Poster:The value of the NCI oncology codetable mapping file for data collection and submission
- Date: April 28th
- Time: 9 AM – 12 PM
